Please login to the form below

Not currently logged in
Email:
Password:

oral myeloma therapy

This page shows the latest oral myeloma therapy news and features for those working in and with pharma, biotech and healthcare.

Takeda can't sway NICE on oral myeloma therapy Ninlaro

Takeda can't sway NICE on oral myeloma therapy Ninlaro

Drug not recommended for NHS use in England and Wales. NICE has stuck to its decision not to recommend Takeda's multiple myeloma therapy Ninlaro for routine use in the NHS ... standard in myeloma treatment and patients in the UK deserve to have access to

Latest news

  • Novel therapies for blood cancers showcased at ASH Novel therapies for blood cancers showcased at ASH

    Meanwhile, CAR-T therapy has also been shown for the first time at this year's ASH to have a therapeutic benefit in multiple myeloma. ... cancer. There was also encouraging new data for Takeda's multiple myeloma therapy Ninlaro (ixazomib; MLN9708), which

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
Can involving patients in design transform the clinical trial experience?
While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...

Infographics